T., B., R., R. K., R., A. C., P., A., S., D., & R., J. (2022). Effect of casirivimab-imdevimab on mild COVID-19 patients with diabetes in reducing oxygen supplementation at 28 days: an observational study. International Journal of Research in Medical Sciences, 10(9), 1983–1987. https://doi.org/10.18203/2320-6012.ijrms20222277